Lumos Diagnostics LDXHF Stock
Lumos Diagnostics Price Chart
Lumos Diagnostics LDXHF Financial and Trading Overview
| Lumos Diagnostics stock price | 0.09 USD |
| Previous Close | 0.0092 USD |
| Open | 0.0092 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0092 - 0.0092 USD |
| 52 Week Range | 0.0066 - 0.25 USD |
| Volume | 9.87K USD |
| Avg. Volume | 943 USD |
| Market Cap | 2.85M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LDXHF Valuation Measures
| Enterprise Value | 5.93M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.24722466 |
| Price/Book (mrq) | 0.17692308 |
| Enterprise Value/Revenue | 0.515 |
| Enterprise Value/EBITDA | -0.293 |
Trading Information
Lumos Diagnostics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -96.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.25 USD |
| 52 Week Low | 0.0066 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.03 USD |
LDXHF Share Statistics
| Avg. Volume (3 month) | 943 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 309.42M |
| Float | 131.46M |
| Short Ratio | N/A |
| % Held by Insiders | 44.32% |
| % Held by Institutions | 20.23% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -194.49% |
| Gross Margin | 6.48% |
| EBITDA Margin | -175.67% |
Management Effectiveness
| Return on Assets (ttm) | -31.28% |
| Return on Equity (ttm) | -144.52% |
Income Statement
| Revenue (ttm) | 11.52M USD |
| Revenue Per Share (ttm) | 0.06 USD |
| Quarterly Revenue Growth (yoy) | -2.19% |
| Gross Profit (ttm) | 1.19M USD |
| EBITDA | -20229000 USD |
| Net Income Avi to Common (ttm) | -41200000 USD |
| Diluted EPS (ttm) | -0.28 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 783K USD |
| Total Cash Per Share (mrq) | 0.004 USD |
| Total Debt (mrq) | 4.78M USD |
| Total Debt/Equity (mrq) | 43.8 USD |
| Current Ratio (mrq) | 0.542 |
| Book Value Per Share (mrq) | 0.052 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12323000 USD |
| Levered Free Cash Flow (ttm) | -5559125 USD |
Profile of Lumos Diagnostics
| Country | United States |
| State | VIC |
| City | Melbourne |
| Address | Level 4 |
| ZIP | 3205 |
| Phone | 61 3 9087 1598 |
| Website | https://lumosdiagnostics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
Q&A For Lumos Diagnostics Stock
What is a current LDXHF stock price?
Lumos Diagnostics LDXHF stock price today per share is 0.09 USD.
How to purchase Lumos Diagnostics stock?
You can buy LDXHF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lumos Diagnostics?
The stock symbol or ticker of Lumos Diagnostics is LDXHF.
Which industry does the Lumos Diagnostics company belong to?
The Lumos Diagnostics industry is Diagnostics & Research.
How many shares does Lumos Diagnostics have in circulation?
The max supply of Lumos Diagnostics shares is 481.31M.
What is Lumos Diagnostics Price to Earnings Ratio (PE Ratio)?
Lumos Diagnostics PE Ratio is now.
What was Lumos Diagnostics earnings per share over the trailing 12 months (TTM)?
Lumos Diagnostics EPS is -0.02 USD over the trailing 12 months.
Which sector does the Lumos Diagnostics company belong to?
The Lumos Diagnostics sector is Healthcare.